Virobay
leaders in protease inhibitor design
Menlo Park, United States · Founded 2006 · $48.0M raised
- Headquarters
- Menlo Park, California
- Employees
- 1–10
- Founded
- 2006
- Business Model
- B2B
- Website
- virobayinc.com
- Total Funding
- $48.0M
- Last Round
- $8.0M Series BJul 2014
- Rounds
- 3
About
Antiviral drug discovery and development company focused on treatments for autoimmune diseases, neuropathic pain, and viral infections.
Summary
Virobay is a Biotech company based in Menlo Park, United States, founded in 2006. It has raised $48.0M in total across 3 rounds, most recently a $8.0M Series B round in Jul 2014. Investors include Sutter Hill, Perceptive Advisors and TPG Biotech.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2014
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...